• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stryker launches T2 Alpha Humerus Nailing System, supporting surgical workflow and care for complex fractures

    2/11/26 9:03:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care
    Get the next $SYK alert in real time by email

    PORTAGE, Mich., Feb. 11, 2026 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, announced the launch of the T2 Alpha Humerus Nailing System, the latest addition to its T2 Alpha portfolio. The system offers surgeons a streamlined approach to humeral fracture fixation while providing hospital teams with a unified platform that enables consistent, high-quality care. 

    Stryker's T2 Alpha Humerus Nailing System

    Designed using Stryker's SOMA (Stryker Orthopaedic Modeling and Analytics) technology, the T2 Alpha Humerus Nailing System helps manage complex humerus fractures, including non-unions, malunions, malalignments and pathological fractures. Its advanced nail design is intended to align with the patient's anatomy, 1 enhance fixation stability, and provide flexibility.

    The T2 Alpha Humerus Nailing System is built to simplify procedures and expand treatment options through intuitive instrumentation and guided targeting, supporting ease of use in the operating room. By integrating with Stryker's existing nailing platform, it promotes familiarity and consistent workflows across procedures, helping to streamline training, reduce tray requirements and support hospital process efficiencies.

    Key features of the T2 Alpha Humerus System include:

    • SOMA-informed nail design based on CT data across diverse populations to facilitate anatomical fit and alignment1
    • Active intraoperative compression of up to 6mm to provide controlled fracture reduction compared to traditional methods6
    • Multiplanar screw fixation with advanced locking options designed to capture dense bone2 and enhance stability4,5
    • Guided targeting instrumentation to promote reproducibility and potentially reduce radiation exposure3

    "With the T2 Alpha Humerus Nailing System, we are giving surgeons greater flexibility to treat complex humerus fractures with confidence," said Eric Tamweber, vice president and general manager of Stryker's Trauma business. "This addition to our T2 Alpha portfolio builds on decades of surgeon collaboration and innovation, delivering solutions designed to support consistent results while driving efficiency in the operating room."

    For more information, visit www.stryker.com/us/en/trauma-and-extremities/products/T2-Alpha-Humeral-Nail.html.

    About Stryker

    Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com.

    Media contact

    Frank Mastrangelo

    Director, Communications

    Stryker Trauma & Extremities

    frank.mastrangelo@stryker.com

    References

    1. Internal Report № D0000353370, Rev AA.



    2. Internal Report № D0000305724, Rev AA.



    3. Konda SR, Maseda M, et al. Observational prospective unblinded case-control study to evaluate the effect of the Gamma3® distal targeting system for long nails on radiation exposure and time for distal screw placement, Injury. 2023;54(2):677-682. doi:10.1016/j.injury.2022.11.046



    4. Naidu SH, Bixler B, Capo JT, Moulton MJ, Radin A. Percutaneous pinning of proximal humerus fractures: a biomechanical study. Orthopedics. 1997;20(11):1073–6.24.



    5. Horn J, Gueorguiev B, Brianza S, Steen H, Schwieger K. Biomechanical evaluation of two-part surgical neck fractures of the humerus fixed by anangular stable locked intramedullary nail. J Orthop Trauma. 2011;25(7):406–13.



    6. T2 Alpha Humerus Nailing System Surgical Technique, TR-T2AL-SURGP-2363750, 09-2025 

    Stryker Logo (PRNewsfoto/Stryker)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/stryker-launches-t2-alpha-humerus-nailing-system-supporting-surgical-workflow-and-care-for-complex-fractures-302682984.html

    SOURCE Stryker

    Get the next $SYK alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SYK

    DatePrice TargetRatingAnalyst
    2/20/2026Outperform
    William Blair
    1/27/2026$387.00Hold
    TD Cowen
    1/6/2026$418.00Mkt Perform → Outperform
    Raymond James
    12/19/2025$440.00Mkt Perform → Mkt Outperform
    Citizens JMP
    9/18/2025$420.00Neutral
    Rothschild & Co Redburn
    2/26/2025$450.00Buy
    Citigroup
    12/2/2024$370.00 → $445.00Equal-Weight → Overweight
    Morgan Stanley
    9/10/2024$405.00Outperform
    Wolfe Research
    More analyst ratings

    $SYK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Stiles Spencer S

    4 - STRYKER CORP (0000310764) (Issuer)

    3/24/26 5:17:58 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Pierce James Andrew

    4 - STRYKER CORP (0000310764) (Issuer)

    3/24/26 5:14:47 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Menon Viju

    4 - STRYKER CORP (0000310764) (Issuer)

    3/24/26 5:11:39 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    $SYK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    William Blair initiated coverage on Stryker

    William Blair initiated coverage of Stryker with a rating of Outperform

    2/20/26 8:25:36 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    TD Cowen resumed coverage on Stryker with a new price target

    TD Cowen resumed coverage of Stryker with a rating of Hold and set a new price target of $387.00

    1/27/26 8:50:06 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    Stryker upgraded by Raymond James with a new price target

    Raymond James upgraded Stryker from Mkt Perform to Outperform and set a new price target of $418.00

    1/6/26 8:28:26 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    $SYK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Stryker to announce financial results for its first quarter of fiscal year 2026

    Portage, Michigan, April 01, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for its first quarter of fiscal year 2026 on Thursday, April 30, 2026.  A press release will be issued at approximately 4:05 p.m. ET and available at Stryker - Press Releases that day. The press release will include summary financial information for the company's first quarter that ended March 31, 2026. Stryker will host a webcast at 4:30 p.m. ET on Thursday, April 30, 2026, to discuss its first quarter 2026 results.  The webcast can be accessed at Stryker - Events & Presentations.  An archive of the webcast will also be available on the company's website two hours afte

    4/1/26 8:00:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    Stryker names Nick Mead Vice President, Investor Relations

    Portage, Michigan, March 31, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK), a global leader in medical technologies, announced today Nick Mead has been appointed Vice President, Investor Relations, effective May 1, 2026. Mead has nearly 20 years of experience at Stryker, with leadership roles spanning multiple divisions and business units across the company. Most recently, he served as Vice President, Finance for Stryker's Medical division, where he partnered closely with senior leaders to support commercial strategy, capital allocation and operational execution. "Nick brings deep institutional knowledge, strong financial expertise and a proven ability to support strategic decision making

    3/31/26 8:00:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    Stryker announces Annual Meeting of Shareholders

    Portage, Michigan, March 23, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced its 2026 Annual Meeting of Shareholders is scheduled as follows: Wednesday, May 6, 2026 – 12:00 p.m. Eastern Time The Meeting will be held virtually via the internet. Information about the webcast, which will include both the audio and the slide presentation from the meeting, is available on the Investor Relations page of our website at www.investorevents.stryker.com. A recording of the annual meeting will also be available from 10:30 a.m., Eastern Time, on Thursday, May 7, 2026 at www.virtualshareholdermeeting.com/SYK2026 until the definitive proxy statement for our 2027 Annual Meeting of Shareholders is

    3/23/26 3:00:00 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    $SYK
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Stryker Corporation

    SCHEDULE 13G/A - STRYKER CORP (0000310764) (Subject)

    3/27/26 1:20:03 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    SEC Form DEFA14A filed by Stryker Corporation

    DEFA14A - STRYKER CORP (0000310764) (Filer)

    3/23/26 1:15:04 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    SEC Form DEF 14A filed by Stryker Corporation

    DEF 14A - STRYKER CORP (0000310764) (Filer)

    3/23/26 1:05:14 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    $SYK
    Financials

    Live finance-specific insights

    View All

    Stryker declares an $0.88 per share quarterly dividend

    Portage, Michigan, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable April 30, 2026, to shareholders of record at the close of business on March 31, 2026, representing an increase of 4.8% versus the prior year and unchanged from the previous quarter.  About Stryker Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 15

    2/4/26 8:00:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    Stryker reports 2025 operating results and 2026 outlook

    Portage, Michigan, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2025: Fourth Quarter Results Reported net sales increased 11.4% to $7.2 billionOrganic net sales increased 11.0%Reported operating income margin of 25.2%Adjusted operating income margin(1) increased 100 bps to 30.2%Reported EPS increased 56.0% to $2.20Adjusted EPS(1) increased 11.5% to $4.47  Fourth Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures OrganicMedSurg and Neurotechnology        17.5        %         0.9        %         16.6        %         4.0        %         12.6        %

    1/29/26 4:05:00 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    VB Spine Completes Acquisition of Cestas Manufacturing Facility from Stryker

    Deal expands global manufacturing footprint and positions VB Spine for future growth in spine care VB Spine LLC ("VB Spine") today completed the acquisition of Stryker's spine implant manufacturing facility in Cestas, France. Known for its state-of-the-art operations and technical capabilities, the Cestas facility will play a central role in VB Spine's global manufacturing strategy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260106463289/en/VB Spine's manufacturing facility in Cestas, France This milestone expands on the April 1, 2025 formation of VB Spine, established through the acquisition of Stryker's U.S. spine implan

    1/6/26 8:57:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    $SYK
    Leadership Updates

    Live Leadership Updates

    View All

    GE HealthCare appoints medtech leader Kevin Lobo to Board of Directors

    GE HealthCare (NASDAQ:GEHC) announced today the appointment of Kevin A. Lobo, Chair and Chief Executive Officer of Stryker Corporation (NYSE:SYK), to its Board of Directors effective March 13. Mr. Lobo brings more than 25 years of medical technology, operational, and financial leadership experience. His clinical expertise and track record of driving innovation and scaling global businesses make him well qualified to contribute to GE HealthCare's strategic priorities. "Kevin is a seasoned healthcare executive with a deep understanding of the medical technology landscape. His knowledge and insight will further strengthen our Board as we continue to build a more personalized, connected and s

    3/17/26 9:00:00 AM ET
    $GEHC
    $SYK
    Medical Electronics
    Health Care
    Medical/Dental Instruments

    Stryker showcases continued innovation across orthopaedics at AAOS 2026 Annual Meeting

    Evolving technologies and offerings reinforce commitment to shaping the future of orthopaedic care PORTAGE, Mich., March 3, 2026 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, showcases its commitment to innovation across orthopaedic specialties with the introduction of the newest additions to the Triathlon® Total Knee System, the expanded Mako SmartRobotics™ portfolio and continued evolution of the power tool portfolio at the American Academy of Orthopaedic Surgeons' (AAOS) 2026 Annual Meeting in New Orleans. Triathlon Gold: Building on the legacy

    3/3/26 8:00:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    Stryker showcases next generation of Mako SmartRobotics™ at AAOS 2025 Annual Meeting

    Latest technology offers more applications and innovation across more specialties MAHWAH, N.J., March 11, 2025 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, showcases the latest advancements in Mako SmartRobotics™ across hip, knee, spine and shoulder procedures at the American Academy of Orthopaedic Surgeons' (AAOS) 2025 Annual Meeting in San Diego. With over 1.5 million Mako procedures performed globally across 45 countries, Mako is a market-leading technology in orthopaedics. With the introduction of Mako Total Hip with Advanced Primary and Rev

    3/11/25 8:03:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    $SYK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Stryker Corporation (Amendment)

    SC 13G/A - STRYKER CORP (0000310764) (Subject)

    2/12/24 10:18:54 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Stryker Corporation (Amendment)

    SC 13G/A - STRYKER CORP (0000310764) (Subject)

    2/14/23 12:37:55 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Stryker Corporation (Amendment)

    SC 13G/A - STRYKER CORP (0000310764) (Subject)

    2/10/23 9:18:16 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care